¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Lymphokine Cytokine Res"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® cytokine ÇÑ±Û ½ÃÅäÄ«ÀÎ
¼³¸í   
  Á¶Á÷ÀÇ ±¹¼Ò¿¡¼­ »ý»êµÇ¾î¼­ ±¹¼ÒÀÇ ¼¼Æ÷°£ÀÇ ½ÅÈ£Àü´ÞÀ» ¸Å°³Çϴ ´Ü¹éÁú ÀÎÀÚÀÇ ÃÑĪÀÌ´Ù. Ç¥Àû¼¼Æ÷ÀÇ ¼ö¿ëü¿¡ °áÇÕÇØ¼­ ¼¼Æ÷³» È°¼ºÈ­ ¸ÞÄ¿´ÏÁòÀ» ¹ßÇö½Ã۴ °ÍÀ¸·Î ¸é¿ª¹ÝÀÀÀÇ Á¦¾î, Ç×¾ÏÀÛ¿ë, Ç×¹ÙÀÌ·¯½ºÀÛ¿ë, ¼¼Æ÷ÀÇ Áõ½Ä-ºÐÈ­ÀÇ Á¶Àý µîÀÇ ÀÛ¿ëÀ» ³ªÅ¸³½´Ù. ÀϹÝÀûÀ¸·Î 10£­12~10£­10 ¸ôÀÇ ±ØÈ÷ ¹Ì·®¿¡¼­ ±â´ÉÇϸ砽żÓÈ÷ ºÐÇØ¼Ò½ÇµÈ´Ù. ¸²ÇÁ±¸°¡ ºÐºñÇϴ ¸²Æ÷Ä«ÀÎ, Å«Æ÷½Ä¼¼Æ÷ À¯·¡ÀÇ ¸ð³ëÄ«ÀÎ, T¼¼Æ÷°¡ ºÐºñÇϴ ÀÎÅÍ·çŲ µîÀÇ ¿©·¯ Á¾·ù°¡ ¾Ë·ÁÁö°í ÀÖÀ¸³ª °¢°¢ÀÇ À¯ÀüÀÚÀÇ ÇØ¸íÀ¸·Î µ¿ÀÏÇÑ °ÍÀÌ ÆÇ¸íµÇ°í ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytokine
    ½ÃÅäÄ«ÀÎ
  • cytokine network
    ½ÃÅäÄ«Àα׹°, ½ÃÅäÄ«ÀÎ³×Æ®¿öÅ©
  • lymphokine
    ¸²Æ÷Ä«ÀÎ
  • lymphokine-activated killer cell
    ¸²Æ÷Ä«ÀÎȰ¼º»ìÇØ¼¼Æ÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytokine
    ½ÃÅäÄ«ÀÎ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytokine
    ½ÃÅäÄ«ÀÎ
  • lymphokine-activated killer cell
    ¸²Æ÷Ä«ÀÎȰ¼º¼¼Æ÷µ¶¼º¼¼Æ÷
  • lymphokine
    ¸²Æ÷Ä«ÀÎ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cytokine
    »çÀÌÅäÄ«ÀÎ
  • RES=£¾reticuloendothelial system
    ¼¼¸Á³»Çǰ³, ¸Á³»°è.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytokine
    »çÀÌÅäÄ«ÀÎ, ¼¼Æ÷È£¸£¸ó.
  • cytokine
    »çÀÌÅäÄ«ÀÎ
  • cytokine
    ½ÃÅäÄ«ÀÎ
  • disease, M ni res
    ¸Þ´Ï¿¡¸£º´
  • reticuloendothelial system =res
    ¼¼¸Á³»Çǰè(á¬ØÑÒ®ù«Í§), ¸Á³»°è(ØÑҮͧ)
  • syndrome, M{0e9}ni{0e8}res
    ¸Þ´Ï¿¡¸£ÁõÈıº
  • lymphokine
    ¸²Æ÷Ų.
  • lymphokine
    ¸²Æ÷Ų.
  • lymphokine activated killer (LAK) cell
    ¸²Æ÷Ä«ÀÎȰ¼º »ìÇØ¼¼Æ÷
  • lymphokine production
    ¸²Æ÷Ų»ý»ê
  • lymphokine reaction
    ¸²Æ÷Ų¹ÝÀÀ
  • lymphokine-activatcd killer cell
    ¸²Æ÷ŲȰ¼ºÈ­ »ì¼¼Æ÷
  • lymphokine-activated killer cell
    ¸²Æ÷Ų-Ȱ¼º »ì¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cytokine
    »çÀÌÅäÄ«ÀÎ
  • lymphokine
    ¸²Æ÷Ä«ÀÎ
  • RES
    (å²) Reticuloendothelial system
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CRF case report form; chronic renal failure; chronic respiratory failure; coagulase-reacting factor; con...
CSIF cytokine synthesis inhibitory factor
LAK T cells Lymphokine Activated Killer T cells
RES Reticulo-Endothelial System
A-LAK adherent lymphokine-activated killer [cell]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RES Reserpine
RES Reticulo Endothelial System
ALAK Adherent lymphokine activated killer
LK Lymphokine
LAK Lymphokine (IL-2)-activated-killer
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 1107
    JournalTitle: Lymphokine and cytokine research.
    MedAbbr: Lymphokine Cytokine Res
    ISSN: 1056-5477
    ESSN:
    IsoAbbr: Lymphokine Cytokine Res.
    NlmId: 9107882
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lymphokine
    ¸²Æ÷Ä«ÀÎ, ¸²Æ÷Ų
    1. Ç׿ø¿¡ ÀÇÇØ Ȱ¼ºÈ­µÈ ¸²ÇÁ±¸°¡ ¹æÃâÇÏ´Â °¡¿ë¼º ´Ü¹é Àü´Þ ¹°ÁúÀÇ ÃÑĪ. 2. Ç׿ø°ú Á¢ÃËÇÏ¿© °¨ÀÛµÈ Àӯı¸¿¡ ÀÇÇØ ºÐºñµÇ´Â ¹°¿¡ ³ì´Â ´Ü¹éÁú Áß°³ÀÚ¸¦ ºÎ¸£´Â °ÍÀÌ´Ù. ´ë½Ä ¼¼Æ÷¸¦ Ȱ¼ºÈ­½Ã۰í Àӯı¸¸¦ º¯Çü½ÃŰ°í ¼¼Æ÷¼º ¸é¿ª¿¡ °ü¿©ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RES <abbreviation> Reticuloendothelial system.
(05 Mar 2000)
receptors, cytokine Cell surface proteins that bind cytokines and trigger intracellular changes influencing the behaviour of cells.
(12 Dec 1998)
cytokine <biochemistry> Small proteins or biological factors (in the range of 5-20 kD) that are released by cells and have specific effects on cell-cell interaction, communication and behaviour of other cells.
Not really different from hormones, but the term tends to be used as a convenient generic shorthand for interleukins, lymphokines and several related signalling molecules such as TNF and interferons.
Generally growth factors would not be classified as cytokines, though TGF is an exception. Rather an imprecise term. Chemokines are a subset of cytokines.
(29 Sep 1997)
killer cells, lymphokine-activated Cytolytic lymphocytes with the unique capacity of killing natural killer (nk)-resistant fresh tumour cells. They are interleukin-2-activated nk cells that have no MHC (major histocompatibility complex) restriction or need for antigen stimulation. Lak cells are used for adoptive immunotherapy in cancer patients.
(12 Dec 1998)
lymphokine <growth factor> Substance produced by a leucocyte that acts upon another cell.
Examples are interleukins, interferon alpha, lymphotoxin (tumour necrosis factor alpha), granulocyte monocyte colony-stimulating factor (GM-CSF). The term is becoming less common and cytokine, a more general term, is taking over. Cytokines include lymphokines.
(20 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphokine
    ¸²Æ÷Ä«ÀÎ(T¼¼Æ÷°¡ ºÐºñÇÏ´Â È­ÇÐ ¹°Áú)
  • RES
    reticuloendothelial system
  • in medias res
    »ç°ÇÀÇ Á߽ɿ¡¼­;»ç°Ç µµÁߺÎÅÍ
  • res
    ¹°;½Çü;¹°°Ç;»ç°Ç;Àç»ê
  • res adjudicata
    =RES JUDICATA
  • res gestae
    ÀÌ·ç¾îÁø ÀÏ;¾÷Àû;(¼Ò¼Û»ç°ÇÀÇ)ºÎ´ë»óȲ(Áõ°Å ´É·ÂÀ» °¡Áø Áß¿äÇÑ »ç½Ç)
  • res judicata
    ±â°á »ç°Ç
  • res.
    research;reserve(d);residence;resides;resigned;resistance;resolution
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á